RxDoctor Payments DataLook up a doctor →

David McHenry, MD

Neurology · Jackson, MSNPI 1053494831

Payments from drug & device makers

$18,366in general payments, 2019–2025

Across 1,023 payments — averaging $17.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$1K
  • AbbVie$1K
  • Novartis$1K
  • Pfizer$958
  • Acadia Pharmaceuticals Inc$933
  • Genentech USA, Inc.$786
  • plus $12K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Teva Pharmaceuticals USA, Inc.75$1,241
AbbVie(2 entities)87$1,177
Novartis81$1,108
Pfizer64$958
Acadia Pharmaceuticals Inc63$933
Genentech USA, Inc.47$786
UCB, Inc.38$690
SK Life Science, Inc.31$682
Sanofi28$629
Argenx US, Inc.20$628
Medtronic(2 entities)34$602
Biogen31$580
Lilly USA, LLC25$569
AstraZeneca(2 entities)29$556
EMD Serono, Inc.25$416
Lundbeck LLC22$410
Otsuka America Pharmaceutical, Inc.16$375
Neurocrine Biosciences, Inc.21$372
Amgen(2 entities)21$365
ANI Pharmaceuticals, Inc.19$357
Sunovion Pharmaceuticals Inc.19$304
Eisai Inc.12$293
E.r. Squibb & Sons, L.L.C.14$266
Acorda Therapeutics, Inc12$245
Catalyst Pharmaceuticals, Inc.9$241
Jazz Pharmaceuticals Inc.12$226
Bristol Myers Squibb15$217
TG Therapeutics, Inc.2$203
Amylyx Pharmaceuticals, Inc.12$185
Avanir Pharmaceuticals, Inc.12$184
Livanova USA, Inc.8$155
Biohaven Pharmaceutical Holding Company Ltd.10$153
GE HealthCare6$145
Microtransponder, Inc.1$136
Neurelis, Inc.2$134
Boehringer Ingelheim1$125
Takeda Pharmaceuticals U.S.A., Inc.7$115
Supernus Pharmaceuticals, Inc.7$99
Sumitomo Pharma America, Inc.6$98
Kyowa Kirin, Inc.5$96
Biohaven Pharmaceuticals, Inc.6$93
MDD US Operations, LLC5$90
Johnson & Johnson(2 entities)5$75
Alnylam Pharmaceuticals Inc.4$69
Greenwich Biosciences, Inc.4$68
Corium, LLC3$67
Mallinckrodt Hospital Products Inc.3$66
Impel Pharmaceuticals Inc.3$62
Amneal Pharmaceuticals LLC4$57
Sanofi-aventis U.S. LLC3$57
Merz Pharmaceuticals, LLC2$54
Vanda Pharmaceuticals Inc.2$50
Grifols USA, LLC3$50
Novocure Inc.3$49
Adamas Pharmaceuticals, Inc.2$43
Axsome Therapeutics, Inc.2$43
Akcea Therapeutics, Inc.2$31
Chiesi USA, Inc.2$31
CSL Behring1$31
Mallinckrodt Enterprises LLC2$30

How this compares

$18,366 in reported general payments places this provider in the 70th percentile of 111 neurology providers in Mississippi.

See all neurology providers in Mississippi

Medicare billing

Part B allowed, 2024
$100,028
Medicare patients
545
Services billed
1,311

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →